Applied Biosystems to Webcast Investor Meeting.

FOSTER CITY, Calif. -- Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, will webcast a meeting with investors on August 15, 2006. The meeting, which will be held at Applied Biosystems' offices in Framingham, Massachusetts, is scheduled to begin at 2:30 p.m. and end at 3:30 p.m. ET. Kevin P. Corcoran, Vice President and General Manager, Genetic Analysis Business Unit, Molecular and Cell Biology Division, and David Hicks, Senior Director, Proteomics and Small Molecule Division, will present overviews of their respective businesses and take questions from investors.

Interested parties who wish to listen to the webcast should visit the "Investors & Media" section of www.applera.com or www.appliedbiosystems.com. It is suggested that listeners access the live webcast 15 minutes before it is scheduled to begin. The webcast replay will be archived on the Presentations page of the Investors & Media section of each website.

About Applera Corporation and Applied Biosystems

Applera Corporation consists of two operating groups. The Applied Biosystems Group serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to make scientific discoveries and develop new pharmaceuticals. Applied Biosystems' products also serve the needs of some markets outside of life science research, which we refer to as "applied markets," such as the fields of: human identity testing (forensic and paternity testing); biosecurity, which refers to products needed in response to the threat of biological terrorism and other malicious, accidental, and natural biological dangers; and quality and safety testing, for example in food and the environment. Applied Biosystems is headquartered in Foster City, CA, and reported sales of $1.9 billion during fiscal 2006. The Celera Genomics Group is focused on discovery, development, and commercialization of diagnostic products as well as leveraging its proteomic, bioinformatic, and genomic capabilities to identify and validate drug targets, and is also seeking to advance therapeutic antibody and selected small molecule drug programs in collaboration with global technology and market leaders. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at http://www.applera.com, or by telephoning 800.762.6923. Information about Applied Biosystems is available at http://www.appliedbiosystems.com.

Copyright(C) 2006. Applera Corporation. All Rights Reserved. Applied Biosystems, AB (Design), and Celera are registered trademarks, and Applera and Celera Genomics are trademarks of Applera Corporation or its subsidiaries in the U. S. and/or certain other countries.